Cite
MLA Citation
Zoe Van de Wyngaert et al.. “Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population.” British journal of haematology, vol. 188, 2020, pp. e24–e27. http://access.bl.uk/ark:/81055/vdc_100099366722.0x000060